Trial Profile
Safety and efficacy study of Different Interval Dose Administration Sifuvirtide for Injection
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Sifuvirtide (Primary)
- Indications Acquired immunodeficiency syndrome; HIV infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors FusoGen Pharmaceuticals
- 20 Jun 2016 New trial record